News & insights

Select content type

Select a practice area

05/09/2022
News

Van Bael & Bellis expands its Transactions Team further with corporate M&A team hire

With a growing Transactions Team that is establishing itself as one of the leading independent practices in the market, Van Bael & Bellis (VBB), a Brussels-based international law firm, is pleased to announce the arrival of leading corporate M&A partner Caroline Daout alongside senior associates Virginie Lescot and Cedric Hauben as well as associates Jens Westerwoudt and Charles-Antoine du Bus.

- 04/10/2023
- News
Health Commissioner Kyriakides Explains in European Parliament Upcoming Measures to Tackle Medicine Shortages and Create EU Healthcare Autonomy

During this week’s plenary session of the European Parliament in Strasbourg, European Commissioner for Health and Food Safety Stella Kyriakides offered a preview of the European Commission’s impending policy measures to tackle medicine shortages and create strategic healthcare autonomy for the European Union
Read more
- 03/10/2023
- News
Sustainability initiatives and Competition Law: The practical perspective - webinar

Download PDF
- 02/10/2023
- News
European Commission Updates Q&A on EU Clinical Trials Regulation

On 29 September 2023, the European Commission published a newly updated version of its Q&A on the EU Clinical Trials Regulation
Download PDF
- 29/09/2023
- News
United Kingdom - Competition Appeal Tribunal Sides Again with CMA in Confirming Finding of Excessive and Unfair Pricing of Hydrocortisone Tablets

On 18 September 2023, the UK Competition Appeal Tribunal (CAT) confirmed in large part a decision of the UK Competition and Markets Authority (CMA) which on 23 July 2021 had imposed fines on several hydrocortisone tablet suppliers for, in addition to another infringement, charging excessive and unfair
Read more
- 25/09/2023
- News
Belgium - Royal Decree Introduces Tendering Rules to Increase Competition for Biological Medicines

On 22 September 2023, the Belgian Official Journal (Belgisch Staatsblad / Moniteur belge) published a Royal Decree of 13 September 2023 “establishing specific rules on public procurement of biological medicines” with a view to increasing competition for biological medicines.
Download PDF
- 22/09/2023
- News
European Parliament Adopts Proposed Regulation on Substances of Human Origin

On 12 September 2023, the European Parliament (the Parliament) adopted in first reading its position on the European Commission’s (the Commission) proposal of 14 July 2022 for a Regulation on standards of quality and safety for substances of human origin intended for human application (SoHOs) (the proposed Regulation; see, Van Bael & Bellis Life Sciences News and Insights, 15 July 2022). The Parliament’s position was adopted in plenary, with 483 votes in favour, 52 against, and 89 abstention
Download PDF
- 20/09/2023
- News
European Commission Carries Out Dawn Raid against Supplier of Cardiovascular Medical Devices

On 19 September 2023, the European Commission (the Commission) and an unspecified national competition authority jointly carried out unannounced inspections at the premises of an as yet anonymous supplier of medical devices for cardiovascular applications (see, attached press release)
Download PDF
- 19/09/2023
- News
VBB partner Alex Stratakis discusses competition and generative AI at IBA competition conference

London-based competition partner Alex Stratakis spoke last week on the role of competition law and policy in controlling artificial intelligence (AI) at the International Bar Association’s 27th Annual Competition Conference
Read more
- 18/09/2023
- News
The new EU Horizontal Guidelines – When do algorithmic pricing tools present particular competition law risks?

Our latest analysis of key aspects of the European Commission’s new horizontals package focuses on the Commission’s approach in the Horizontal Guidelines to algorithmic pricing tools, which are increasingly used across industries.
Download PDF

Showing 1-9 of 1890 insights